gopubmed logo
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 19 Dec 2016.

ATPase, class II, type 9A

Top mentioned proteins: CAN, V1a, HAD, Serum albumin, ACID
Papers using IIa antibodies
EV71 induces COX-2 expression via c-Src/PDGFR/PI3K/Akt/p42/p44 MAPK/AP-1 and NF-κB in rat brain astrocytes
Yang Chuen-Mao et al., In Journal of Neuroinflammation, 2009
... PP1, AG1478, LY294002, SH-5, BQ-123, BQ-788, GP antagonist-2, GP antagonist-2A, U0126, SB202190, SP600125, and tanshinone IIA were from Biomol (Plymouth Meeting, PA) ...
Calmodulin kinase II-dependent transactivation of PDGF receptors mediates astrocytic MMP-9 expression and cell motility induced by lipoteichoic acid
Yang Chuen-Mao et al., In Journal of Neuroinflammation, 2009
... GF109203X, Gö6976, apocynin, diphenylene iodonium (DPI), tanshinone IIA (TSIIA) and GR343 were from Biomol (Plymouth Meeting, PA) ...
The expression and the functional roles of tissue factor and protease-activated receptor-2 on SW620 cells
McCarty Owen J. T. et al., In Frontiers in Oncology, 2007
... Human coagulation factors VIIa, Xa, IIa, and fluorescein-conjugated d-Phe-Pro-Arg-chloromethyl ketone (PPACK) were purchased from Haematologic Technologies (Essex Junction, VT, ...
The structure and regulation of vinculin
Takeichi Masatoshi et al., In The Journal of Cell Biology, 2005
... The following antibodies were purchased: rabbit polyclonal anti–αE-catenin, mouse monoclonal anti-vinculin, rabbit polyclonal anti-myosin IIA and IIB, and rabbit polyclonal anti–l-afadin antibodies (Sigma-Aldrich); rabbit polyclonal anti-myosin IIB antibody (Covance); rabbit polyclonal anti-EGFP antibody (MBL); mouse monoclonal anti-EPLIN antibody ...
more suppliers
Papers on IIa
Identification of miRNAs and differentially expressed genes in early phase non-small cell lung cancer.
Yuan et al., Cangzhou, China. In Oncol Rep, Feb 2016
The microarray data of NSCLC in stage IA, IB, IIA, and IIB (GSE50081), were downloaded from the Gene Expression Omnibus (GEO) database.
The relevance of JAK2 in the regulation of cellular transport.
Dërmaku-Sopjani et al., Pristina, Serbia. In Curr Med Chem, Jan 2016
As a powerful regulator of transport mechanisms across the cell membrane, JAK2 regulates a wide variety of potassium, calcium, sodium and chloride ion channels, multiple Na+-coupled cellular carriers including EAAT1-4, NaPi-IIa, SGLT1, BoaT1, PepT1-2, CreaT1, SMIT1, and BGT1 as well as Na+/K+-ATPase.
Mitochondrial Dynamics Is a Distinguishing Feature of Skeletal Muscle Fiber Types and Regulates Organellar Compartmentalization.
Chan et al., Pasadena, United States. In Cell Metab, Jan 2016
Switching of a glycolytic fiber to an oxidative IIA type is associated with elongation of mitochondria, suggesting that mitochondrial fusion is linked to metabolic state.
Growth and differentiation factor 11 (GDF11): Functions in the regulation of erythropoiesis and cardiac regeneration.
Vergely et al., Dijon, France. In Pharmacol Ther, Dec 2015
The binding of activins to activin type IIA (ActRIIA) or type IIB (ActRIIB) receptors induces the recruitment and phosphorylation of an activin type I receptor which then phosphorylates the Smad2 and Smad3 intracellular signaling proteins.
Effect of hyperphosphatemia on gene expression of the Na-Pi cotransporter in rats.
Chou et al., Zhengzhou, China. In Genet Mol Res, Dec 2015
We investigated the effect of high phosphorus content on the sodium-phosphate cotransporter (NaPi-IIa and NaPi-IIl).
Human topoisomerase II alpha as a prognostic biomarker in cancer chemotherapy.
Abd Hamid et al., Kuantan, Malaysia. In Tumour Biol, Nov 2015
Among all forms of topoisomerases, TOP-IIA is extensively associated with cell proliferation and therefore is an important therapeutic target in diseases that involved cellular proliferation such as cancers.
Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs.
Granger et al., Amsterdam, Netherlands. In Lancet, Aug 2015
In the past decade, oral agents have been developed that directly block the activity of thrombin (factor IIa), as well as drugs that directly inhibit activated factor X (Xa), which is the first protein in the final common pathway to the activation of thrombin.
Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments.
Simon et al., Boston, United States. In Lancet, Aug 2015
Treatment options now include the next-generation antiplatelet drugs prasugrel and ticagrelor, and, in terms of anticoagulants, inhibitors that directly target factor IIa (dabigatran) or Xa (rivaroxaban, apixaban, edoxaban) are available.
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105.
Ford et al., Stanford, United States. In J Clin Oncol, Jul 2015
RESULTS: Among 80 patients, median age was 48 years; 19 patients (24%) had germline BRCA1 or BRCA2 mutations; clinical stage was I (13%), IIA (36%), IIB (36%), and IIIA (15%).
Comparing Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation, Venous Thromboembolism, and Mechanical Heart Valves.
Rai et al., Oklahoma City, United States. In Consult Pharm, 2014
DATA SOURCES: A Medline search of English-language studies published between 2000 and March 2015 was conducted to identify pertinent papers using combinations of the following words: apixaban, atrial fibrillation, dabigatran, direct oral anticoagulant, edoxaban, factor IIa inhibitors, factor Xa inhibitors, mechanical heart valves, novel oral anticoagulant, rivaroxaban, venous thromboembolism, and warfarin.
Utilizing small nutrient compounds as enhancers of exercise-induced mitochondrial biogenesis.
Philp et al., Worcester, United States. In Front Physiol, 2014
At the cellular level, this adaptive response is manifested by an increased number of oxidative fibers (Type I and IIA myosin heavy chain), an increase in capillarity and an increase in mitochondrial biogenesis.
Bortezomib-based treatment of acute antibody-mediated rejection: a case report.
Zhang et al., Beijing, China. In Genet Mol Res, 2014
At follow-up 6 months after bortezomib treatment, we observed: 1) serum creatinine stabilized at 130 μM from a peak level of 337 μM; 2) PRA decreased from a maximum of 66.7 to 0%; 3) blood plasma cell percentage rebounded after significantly decreasing following the first dose of bortezomib; 4) in renal allograft biopsy, immunohistochemical staining for C4d shifted from strongly positive to negative, and cellular rejection shifted from type IIA to borderline; and 5) adverse effects such as platelet suppression, hypotension, and grade 3 peripheral neuropathy emerged.
Phase IIa trial of trastuzumab emtansine with pertuzumab for patients with human epidermal growth factor receptor 2-positive, locally advanced, or metastatic breast cancer.
Burris et al., Indianapolis, United States. In J Clin Oncol, 2014
PURPOSE: Our phase IIa study characterized the safety and efficacy of two human epidermal growth factor receptor 2 (HER2) -targeted agents, trastuzumab emtansine (T-DM1) and pertuzumab, in patients with HER2-positive metastatic breast cancer (MBC).
Physiological and Structural Differences Between Enterococcus faecalis JH2-2 and Mutant Strains Resistant to (P)-Divercin RV41.
Drider et al., Nantes, France. In Probiotics Antimicrob Proteins, 2010
These mutant strains were recently isolated and characterized for their intermediate resistance to recombinant DvnRV41; a subclass IIa bacteriocin produced by Escherichia coli.
Characterisation of an Antilisterial Bacteriocin Produced by Lactobacillus sakei CWBI-B1365 Isolated from Raw Poultry Meat and Determination of Factors Controlling its Production.
Thonart et al., Gembloux, Belgium. In Probiotics Antimicrob Proteins, 2009
Amongst 101 lactic acid bacteria isolated from meat and fish samples, strain CWBI-B1365, identified as Lactobacillus sakei, was found to produce the subclass IIa bacteriocin sakacin G. Partial sequencing of the gene involved in the biosynthetic pathways revealed an unusual gene organisation in that the accessory gene associated with bacteriocin transport did not occur immediately downstream of the gene encoding an ABC transporter, but upstream of the putative immunity gene and encoded on the opposite DNA strand.
More papers using IIa antibodies
MAP kinases and cell migration
Yang Chuen-Mao et al., In Journal of Neuroinflammation, 2003
... BAPTA/AM, thapsigargin (TG), calmidazolium chloride (CaMI), KN-62, AG1296, LY294002, SP600125, and tanshinone IIA (TSIIA) were from Biomol (Plymouth Meeting, PA, USA) ...
Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation
Chen Cheng-Nan et al., In Journal of Biomedical Science, 2000
... Tanshinone IIA (TIIA) were purchased from Biomol (Plymouth Meeting, PA) ...
Platelet activating factor (PAF) antagonists on cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC)
Sun Grace Y et al., In Journal of Neuroinflammation, 1999
... Antibodies for Western blot are: (1) sPLA2-IIA human, rabbit polyclonal antibody (BioVendor, Candler, NC); (2) goat ...
share on facebooktweetadd +1mail to friends